Publications by authors named "Andre Habel"

Claim this Profile
A
A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
Samantha Brandler, Claude Ruffié, Chantal Combredet, Jean-Baptiste Brault, Valérie Najburg, André Habel

Vaccine· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies.
Carmen Giefing, Andreas L Meinke, Markus Hanner, Tamás Henics, Minh Duc Bui, Andre Habel

J Exp Med· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage.
Steven Hagens, André Habel, Udo Bläsi

Microb Drug Resist· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage.
Steven Hagens, André Habel, Uwe von Ahsen, Alexander von Gabain, Udo Bläsi

Antimicrob Agents Chemother· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames.
Sylvain Cardinaud, Arnaud Moris, Michèle Février, Pierre-Simon Rohrlich, Laurence Weiss, André Habel

J Exp Med· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced virulence of a hfq mutant of Pseudomonas aeruginosa O1.
Elisabeth Sonnleitner, Steven Hagens, Frank Rosenau, Susanne Wilhelm, André Habel

Microb Pathog· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis